The prevalence of hepatitis C virus antibodies among hemodialysis patients.
about
Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia majorRisk of liver disease in HCV-seropositive kidney transplant recipientsPrevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patientsHepatitis C markers in hemodialysis patientsVirological features of hepatitis C virus infection in hemodialysis patientsHepatitis C-virus (HCV) antibodies in patients after kidney transplantation.Nonhepatic manifestations and combined diseases in HCV infection.Chronic viral hepatitis in hemodialysis patients.Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-upHepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern IranCommunity-based seroepidemiological survey of HCV infection in Catalonia, Spain.High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center.High frequency of antibodies to Hantaan virus and hepatitis C virus in chronic haemodialysis patients. Coincidence or cross-reaction?Hepatitis in patients with end-stage renal disease.Gastrointestinal function in chronic renal failure.Hepatitis C Virus Infection in Haemodialysis Patients: "Wolf in Sheep's Clothing".Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them.Seropositivity to hepatitis C virus in Saudi haemodialysis patients.Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan.Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis.Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera.Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus.Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.GB virus-C infection among chronic haemodialysis patients: clinical implications.Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients.Prospective virological follow-up of hepatitis C infection in a haemodialysis unit.Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant.Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women.Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease.Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus.Acute hepatitis C in patients receiving hemodialysis.Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV.A shield against a monster: Hepatitis C in hemodialysis patients.Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients.
P2860
Q27469330-750AA995-31A9-4426-B4B7-EAA67C833E4DQ27472442-EDD349A6-7AEB-40DC-858C-2F0BE6F81CAEQ27477958-168F2CE8-8983-4E0D-ABA5-F350C4FCB3CAQ27488215-C0A89712-5582-4736-8DAB-159DD92DDAC7Q27488263-E2C1CD68-0A2A-4049-B145-0D1C262E1451Q33339419-B484944C-A261-4855-BF18-5445E27E5CFFQ33498313-8F9E9A39-907F-41EC-BC9B-40A0C4D6459AQ36271099-343D4B2E-35D2-4F8F-8A67-5AA73164017EQ36496475-EAE635ED-AAAF-497B-882C-8377EF9CB16CQ37417388-CD6677D0-85B3-48D1-B546-AFB631114D63Q39587848-794A640E-8F7D-48E3-8D79-4AF628EB94D6Q39606438-A480C71D-7783-4CDF-AD11-ED6BF05B5541Q40709348-D3181BBA-5A8E-45D8-90D5-F518BCBEA1A9Q40874165-210A30F9-0F5F-4DF5-805A-FDB997AF697AQ41069912-36E53E5B-A438-4C4F-B40D-5A6026C9821EQ41863583-70C3ACF2-1A1C-4BA4-A18E-1F41D1EF0497Q42978570-3DD44FEA-E2C2-45EC-8B64-9AC0C84BE099Q42980672-F4F24BC0-C974-40D1-AD97-92B0746A4469Q42981867-AFEC8D31-301A-4009-9EB3-F729689169F8Q42983182-8338CB9B-8812-4CAA-970C-CE7836EA055FQ42983311-BE9A2D44-0364-4ED6-A251-51563D65AD75Q42984774-154F40CE-CED7-4D11-9D84-20138A7EE67EQ42985827-EBE160D9-8465-4F9D-9079-CDB84D0DB948Q42986046-894F61B2-1DD2-4C4A-9F73-BAFDF32EF590Q42986177-42BE03D3-4D57-49AC-B022-7FCFC6DD2833Q42986562-9F9450A2-16D0-4A51-9425-B39E89BB92A7Q42987785-AF136AB2-0207-4EF2-924C-4165ED6DCAADQ43035020-DB2DBD81-27BE-4F08-8C43-66FE01576333Q43036581-0581038A-35B8-4CCB-BD56-9913E21A3992Q43038527-1EB5C2F0-3A2A-440D-A57B-BAAB493777A0Q43038776-DDDB78EB-9BD9-41E5-92C4-2C4332872C76Q43038890-37A70A33-8F77-46C4-BB88-1AECB88E46FCQ43040366-8326D16E-A530-4415-B010-4CA0DC0D18B3Q43049124-DDA6EA3C-660D-4009-A60E-FE784C38DB14Q43165948-3E1C34B8-4648-4DB0-9E92-439B0AAD47FBQ45747309-FE8EF1F1-0160-4986-B736-BEB1F7092AEC
P2860
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@en
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@nl
type
label
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@en
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@nl
prefLabel
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@en
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@nl
P2093
P1476
The prevalence of hepatitis C virus antibodies among hemodialysis patients.
@en
P2093
P304
P356
10.7326/0003-4819-112-12-958
P407
P577
1990-06-01T00:00:00Z